Sabna Kotta
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Abdul Wadood Khan
Mylan Laboratories Ltd. Bangalore, India
Shahid H. Ansari
Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard University, New Delhi-110062, India
Rakesh Kumar Sharma
Saveetha Institute of Medical and Technical Sciences, 162, Poonamallee High Road, Chennai-600077, Tamil Nadu, India
Y.T. Kamal
Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 611441, Saudi Arabia
Hibah Mubarak Aldawsari
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Nabil Abdulhafiz Alhakamy
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Sanjula Baboota
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India
Javed Ali
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India
LiveDNA: 91.23760
PDF Fulltext XML References Citation
How to cite this article
Sabna Kotta, Abdul Wadood Khan, Shahid H. Ansari, Rakesh Kumar Sharma, Y.T. Kamal, Hibah Mubarak Aldawsari, Nabil Abdulhafiz Alhakamy, Sanjula Baboota and Javed Ali, 2022. Efavirenz nanoemulsion: Formulation Optimization by Box-Behnken Design, in vivo Pharmacokinetic Evaluation and Stability Assessment. International Journal of Pharmacology, 18: 732-745.
DOI: 10.3923/ijp.2022.732.745
URL: https://scialert.net/abstract/?doi=ijp.2022.732.745
DOI: 10.3923/ijp.2022.732.745
URL: https://scialert.net/abstract/?doi=ijp.2022.732.745